The ALPHAMEDIX-02 trial assessed 212Pb-DOTAMTATE in PRRT-naïve and PRRT-exposed GEP-NET patients, showing promising efficacy in both cohorts. PRRT-naïve patients exhibited a 60% response rate, while ...
212Pb-DOTAMTATE showed significant antitumor activity in PRRT-exposed GEP-NET patients, with a 34.6% ORR and 96.2% disease control rate per investigator review. Investigator-assessed 18-month PFS and ...
Indonesia relocates residents due to Caesium-137 contamination; New York and California support Planned Parenthood against federal funding cuts; English doctors strike for job security and pay; US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback